David S. Miller - Concepedia

Author

David S. Miller

The University of Texas Southwestern Medical Center ORCID

Also Known As

Aloisio, Gina M., Amber L. Johns, Bhavana Pothuri, Boggess, John F., D MILLER, D Miller, D S MILLER, D S Miller, D. MILLER, D. Miller

Publications

42.8K

Citations

101

H-Index

530

Concepts

All Affiliations

The University of Texas Southwestern Medical Center National Institute of Environmental Health Sciences National Institutes of Health Gynecologic Oncology Group Mount Desert Island Biological Laboratory

About

David S. Miller is an author at The University of Texas Southwestern Medical Center specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	20	35	1.3K
2	Health Sciences	18	19	1.1K
3	Education	9	9	222
4	Business	1	1	113
5	Language Studies	1	1	14

David S. Miller

421

Publications

32.4K

Citations

H-Index

Page 1

	Year	Citations
Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment Zahinoor Ismail, Eric E. Smith, Yonas E. Geda, Alzheimer s & Dementia	2015	793
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. Eric Hailman, Henri S. Lichenstein, Mark M. Wurfel, The Journal of Experimental Medicine Recombinant LbpProteinlipid InteractionProtein FunctionSignal TransductionBiochemistry	1994	751
Soluble CD14 participates in the response of cells to lipopolysaccharide. E.A. Frey, David S. Miller, T G Jahr, The Journal of Experimental Medicine ImmunologyImmune RegulationPathologyImmunologic MechanismAntigen Processing	1992	693
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum‐Gamez, Journal of the National Comprehensive Cancer Network Surgical OncologyEpithelial Ovarian CancerCancer ManagementPelvic Reconstructive SurgeryGynecology	2021	688
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study David H. Moore, John A. Blessing, Richard P. McQuellon, Journal of Clinical Oncology	2004	634
Annual Report to the Nation on the Status of Cancer, 1973-1996, With a Special Section on Lung Cancer and Tobacco Smoking Phyllis A. Wingo, Lynn A. G. Ries, Gary A. Giovino, JNCI Journal of the National Cancer Institute	1999	588
Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study Harry J. Long, Brian N. Bundy, Edward C. Grendys, Journal of Clinical Oncology	2005	554
Prophylactic Atenolol Reduces Postoperative Myocardial Ischemia Arthur W. Wallace, Beth Layug, Ida Tateo, Anesthesiology	1998	548
The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations Zahinoor Ismail, Luis Agüera-Ortíz, Henry Brodaty, Journal of Alzheimer s Disease	2017	519
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller, The Lancet Oncology OncologyMetronomic TherapyGynecologyNiraparib MonotherapyLate-line Treatment	2019	516

Page 1